
Teva will stop research into oncology and women’s health in order to cut costs and focus more on generics and …

Abbott is to sell the portion of its branded generics business which operates in developed markets such as Europe to …

Having just announced closing half of its manufacturing sites Teva has now confirmed that chairman Dr Phillip Frost is to …

Teva Pharmaceutical Industries is to close around half of its 75 manufacturing sites within the next five years, chief financial …

Teva is to close 11 of its production sites, with another 16 facilities ‘under evaluation’, as part of a major …
The Food and Drug Administration is to put more inspectors on the ground in India, following a visit there by …

The FDA has been given $20 million to help it assess generic treatments, a group of drugs that makes up …

The CHMP has given Teva Pharmaceutical Industries a lift by recommending that its generic version of AstraZeneca’s lung drug Symbicort …

Teva Pharmaceuticals is under investigation by US authorities for sales and marketing activity around two of its drugs – including …
Merck KGaA is to take big strides into the world of biosimilars, according to the German company’s chairman Karl-Ludwig Kley. …

Gilead has announced the unusual step of allowing its new and highly expensive hepatitis C pill to be sold as …

Actavis is to sell its commercial operations in seven European countries to Aurobindo Pharma in a bid to put more …

The boss of generic drug manufacturer Actavis says his company is pulling out of China because the business environment there …

The world’s biggest generic drugmaker Teva has appointed the chief executive of the world’s biggest generic agrochemical company. Vigodman joins …